Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
SVRA | Savara Inc | Pratt Raymond Dennis | Chief Medical Officer | Jun 26, 2023 | Buy | $2.93 | 6,500 | 19,045 | 160,000 | Jun 27, 2023, 07:00 AM | |
SVRA | Savara Inc | Pratt Raymond Dennis | Chief Medical Officer | Dec 22, 2022 | Buy | $1.54 | 3,500 | 5,402 | 153,500 | Dec 22, 2022, 03:22 PM | |
RMTI | ROCKWELL MEDICAL, INC. | Pratt Raymond Dennis | VP of Drug Development | Apr 26, 2020 | Option Exercise | $2.27 | 4,612 | 10,469 | 353,358 | Apr 27, 2020, 02:38 PM | |
RMTI | ROCKWELL MEDICAL, INC. | Pratt Raymond Dennis | VP of Drug Development | Jun 21, 2017 | Option Exercise | $7.20 | 76,230 | 548,856 | 317,970 | Jun 23, 2017, 04:58 PM | |
RMTI | ROCKWELL MEDICAL, INC. | Pratt Raymond Dennis | VP of Drug Development | Aug 13, 2015 | Buy | $11.54 | 5,000 | 57,675 | 160,700 | Aug 14, 2015, 09:30 AM | |
RMTI | ROCKWELL MEDICAL, INC. | Pratt Raymond Dennis | VP of Drug Development | May 01, 2015 | Option Exercise | $9.64 | 34,650 | 334,026 | 155,700 | May 05, 2015, 05:17 PM | |
RMTI | ROCKWELL MEDICAL, INC. | Pratt Raymond Dennis | VP of Drug Development | Mar 02, 2015 | Option Exercise | $10.47 | 34,650 | 362,786 | 190,350 | Mar 03, 2015, 05:01 PM |